Tier 4 — mechanistic
Commentary: Efficacy and safety of low-molecular-weight collagen peptides in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial
Frontiers in Nutrition
2025
12:1712455
Bibliography
- Funding
- Commentary authors report no financial support.
- Competing interests
- Commentary authors declared no commercial or financial conflicts.
Study snapshot
| Design | Independent published methodological commentary on Park et al. 2025 OA RCT. |
|---|---|
| Model | Critique of a trial of 80 adults with knee OA. |
| Sample | No new participants; commentary on published RCT. |
| Intervention | No new intervention. |
| Duration | Not applicable. |
| Endpoints | Randomization balance; Attrition; Per-protocol versus ITT; Clinical significance; VAS versus WOMAC consistency |
What the study showed, in plain terms
Key findings
What this study can and cannot tell us
Editorial review
Reviewed by the Biohack Blueprint research team
Last verified



